SCHEMBL6780458

SCHEMBL6780458

CC(C)(C)OC(=O)c1ccc(OCCCl)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.53
RAB9A P51151 1/20 0.47
L3MBTL1 Q9Y468 3/20 0.46
GAA P10253 1/20 0.45
CA12 O43570 2/20 0.44
CA1 P00915 2/20 0.44
CA2 P00918 2/20 0.44
CA9 Q16790 2/20 0.44
CA14 Q9ULX7 1/20 0.44
ELANE P08246 2/20 0.42
ADRB2 P07550 1/20 0.42
ADRB1 P08588 1/20 0.42
ADRB3 P13945 1/20 0.42
TSHR P16473 2/20 0.42
TDP1 Q9NUW8 1/20 0.41
PPARA Q07869 1/20 0.41
GPR119 Q8TDV5 1/20 0.41
PKM P14618 1/20 0.41
MAPK1 P28482 1/20 0.41
TP53 P04637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7409800 0.94 MAPT (0.53) MAPTRAB9AL3MBTL1GAACA12
SCHEMBL578611 0.85 MAPT (0.54) MAPTRAB9AL3MBTL1GAACA12
SCHEMBL7035911 0.84 L3MBTL1 (0.53) MAPTRAB9AL3MBTL1GAATDP1
SCHEMBL4843176 0.84 MAPT (0.53) MAPTRAB9AL3MBTL1GAACA12
SCHEMBL19497928 0.83 CA12 (0.54) MAPTRAB9AL3MBTL1GAACA12
SCHEMBL11887264 0.81 PARP10 (0.58) MAPTRAB9AL3MBTL1GAA
SCHEMBL6835771 0.81 MAPT (0.79) MAPTRAB9AL3MBTL1GAACA1
SCHEMBL4057232 0.81 L3MBTL1 (0.53) MAPTRAB9AL3MBTL1CA12CA1
SCHEMBL11032267 0.81 GAA (0.54) MAPTRAB9AL3MBTL1GAACA12
SCHEMBL26088754 0.81 GAA (0.54) MAPTRAB9AL3MBTL1GAACA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2003501424-A 2003-01-14 JP claimed
EP-1183251-A1 INDOLYLPIPERIDINE DERIVATIVES AS ANTIHISTAMINIC AND ANTIALLERGIC AGENTS Almirall Prodesfarma, S.A. (ES) 2002-03-06 EP claimed
WO-2000075130-A1 INDOLYLPIPERIDINE DERIVATIVES AS ANTIHISTAMINIC AND ANTIALLERGIC AGENTS ALMIRALL PRODESFARMA, S.A. (ES) 2000-12-14 WO claimed
EP-1183251-B1 INDOLYLPIPERIDINE DERIVATIVES AS ANTIHISTAMINIC AND ANTIALLERGIC AGENTS ALMIRALL PRODESFARMA SA (ES) 2004-02-11 EP disclosed
US-6683096-B2 Indolylpiperidine derivatives as antihistaminic and antiallergic agents ALMIRALL PRODESFARMA, S.A. (ES) 2004-01-27 US disclosed
US-20020147344-A1 Indolylpiperidine derivatives as antihistaminic and antiallergic agents ALMIRALL PRODESFARMA, S.A. (ES) 2002-10-10 US disclosed
EP-1183251-A1 INDOLYLPIPERIDINE DERIVATIVES AS ANTIHISTAMINIC AND ANTIALLERGIC AGENTS Almirall Prodesfarma, S.A. (ES) 2002-03-06 EP disclosed
WO-2000075130-A1 INDOLYLPIPERIDINE DERIVATIVES AS ANTIHISTAMINIC AND ANTIALLERGIC AGENTS ALMIRALL PRODESFARMA, S.A. (ES) 2000-12-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020147344-A1 Indolylpiperidine derivatives as antihistaminic and antiallergic agents HRH2, HRH1, HRH4 MAPT 3604/4885RAB9A 2169/4885L3MBTL1 4609/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.